Alejandra M. Petrilli

Author

University of Central Florida ORCID

Also Known As

A M Petrilli, A. Petrilli, Alejandra M Petrilli, Alejandra M. Petrilli, Alejandra M. Petrilli⁎, Alejandra Petrilli

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Central Florida Nationwide Children's Hospital The Ohio State University Massachusetts Eye and Ear Infirmary Massachusetts General Hospital

About

Alejandra M. Petrilli is an author at University of Central Florida specializing in medicine, cell biology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	632
2	Cell Biology	4	4	632
3	Health Sciences	2	2	70
4	Engineering	1	1	30
5	Language Studies	1	1	39

Alejandra M. Petrilli

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity Wenjun Song, Jin Chen, Alejandra M. Petrilli, Nature Medicine MitophagySignal TransductionMitochondrial FunctionEnzymatic ActivityMitochondrial Dynamic	2011	536
S-Nitrosylation of DRP1 Does Not Affect Enzymatic Activity and is Not Specific to Alzheimer's Disease Blaise Bossy, Alejandra M. Petrilli, Eva Klinglmayr, Journal of Alzheimer s Disease	2010	154
The Actin-Severing Protein Cofilin Is Downstream of Neuregulin Signaling and Is Essential For Schwann Cell Myelination Nicklaus A. Sparrow, Maria Elisa Manetti, Marga Bott, Journal of Neuroscience	2012	50
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, PLoS ONE	2021	49
Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology Yury O. Núñez López, Anton Iliuk, Alejandra M. Petrilli, International Journal of Molecular Sciences	2022	43
Multimodal assessment of hemispheric lateralization for language and its relevance for behavior Claudia Piervincenzi, Alejandra M. Petrilli, Andrea Marini, NeuroImage Cognitive ScienceHemispheric LateralizationNeurolinguisticsLanguage AcquisitionLanguage Science	2016	39
A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2. Alejandra M. Petrilli, Marisa A. Fuse, Mathew S Donnan, PubMed Chemoprevention StrategyPathologyGliomaTumor BiologyNeuroinflammation	2014	35
Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development Marisa A. Fuse, Christine T. Dinh, Jérémie Vitte, Neuro-Oncology	2019	35
Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells Alejandra M. Petrilli, Jeanine Garcia, Marga Bott, Oncotarget	2017	32
Coordinated regulation of gene expression and microRNA changes in adipose tissue and circulating extracellular vesicles in response to pioglitazone treatment in humans with type 2 diabetes Yury O. Núñez López, Anna Casu, Zuzana Kováčová, Frontiers in Endocrinology ImmunologyExtracellular MicrovesiclesInsulin SignalingPparγ AgonistObesity	2022	31

Page 1